Mark Allen O’Rourke

Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Frances A. Shepherd, Janet Dancey, Rodryg Ramlau et al. · Journal of Clinical Oncology · 2000 · 2.2K citations

Medicine, Oncology, Pharmacology +16

How clonal are bacteria?

John Maynard Smith, N. H. Smith, Mark Allen O’Rourke et al. · Proceedings of the National Academy of Sciences · 1993 · 1.8K citations

Life Sciences, Genetics, Microbiology +17

Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500

Jeffrey B. Smerage, William E. Barlow, Gabriel N. Hortobágyi et al. · Journal of Clinical Oncology · 2014 · 646 citations · Full text

Medicine, Oncology, Pharmacology +17

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Michael B. Atkins, Sandra J. Lee, Bartosz Chmielowski et al. · Journal of Clinical Oncology · 2022 · 439 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089

Daniel G. Haller, Paul J. Catalano, John S. Macdonald et al. · Journal of Clinical Oncology · 2005 · 393 citations · Full text

Medicine, Oncology, Pharmacology +9